Cambridge Investment Research Advisors, Inc. G1 Therapeutics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 16,711 shares of GTHX stock, worth $119,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,711
Previous 16,811
0.59%
Holding current value
$119,149
Previous $73,000
47.95%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GTHX
# of Institutions
101Shares Held
20.1MCall Options Held
1.87MPut Options Held
1.18M-
Black Rock Inc. New York, NY3.08MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$17.8 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.36MShares$9.71 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.25MShares$8.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.08MShares$7.7 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $305M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...